Fun Fact! Statin-associated muscle symptoms (SAMS) occur in 10–29% of patients, typically presenting as myalgia or myositis in the thighs or calves. Severe cases like rhabdomyolysis are rare. Genetic variations, especially in the SLCO1B1 gene, have been linked to a higher risk of developing SAMS during statin treatment.
Could SLCO1B1 genetic testing support safer, more personalized statin prescribing?

Could SLCO1B1 genetic testing support safer, more personalized statin prescribing?

